We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current THAR market cap is 2.93M. The company's latest EPS is USD -6.2710 and P/E is -0.31.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.85M | -2.53M | -2.35M | -2.37M | -3.87M |
| Net Income | -1.82M | -2.47M | -2.26M | -2.33M | -3.8M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -1.81M | -3.21M | -6.88M | -9.46M |
| Net Income | -2.42M | -2.21M | -8.47M | -9.32M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 3.17M | 10.95M | 8.89M | 8.26M | 5.25M |
| Total Liabilities | 1.41M | 1.82M | 1.84M | 1.56M | 2.23M |
| Total Equity | 1.76M | 9.13M | 7.05M | 6.69M | 3.02M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 295k | 622k | 6.69M | 10.95M |
| Total Liabilities | 4.01M | 5.31M | 1.15M | 1.82M |
| Total Equity | -3.72M | -4.69M | 5.54M | 9.13M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -5.89M | -7.3M | -2.83M | -5M | -7.87M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 2.06M | 11.72M | 317k | 1.97M | 1.71M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.08M | -1.09M | -6.56M | -7.3M |
| Investing | N/A | N/A | N/A | N/A |
| Financing | 1.23M | 899k | 13.06M | 11.72M |
| Market Cap | 2.93M |
| Price to Earnings Ratio | -0.31 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.27 |
| Price to Book Ratio | 0.32 |
| Dividend Yield | - |
| Shares Outstanding | 1.49M |
| Average Volume (1 week) | 67.24k |
| Average Volume (1 Month) | 52.54k |
| 52 Week Change | -70.42% |
| 52 Week High | 7.7085 |
| 52 Week Low | 1.835 |
| Spread (Intraday) | 0.59 (23.05%) |
| Company Name | Tharimmune Inc |
| Address |
16192 coastal hwy lewes, delaware 19958 |
| Website | https://www.hillstreambio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
